Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arlen

Showing results (21-30 of 215) with videos related to

Pageof 22
Sort By:
Idrugs : the Investigational Drugs Journal|December 24, 2005
Abiraterone. Cougar BiotechnologyRavi A Madan, Philip M Arlen
Expert Opinion on Biological Therapy|November 23, 2019
Rationale, discovery and clinical development of NEO-201Philip M Arlen, Maria Pia Morelli
Southern Medical Journal|January 1, 1995
Multiple myeloma after treatment of essential thrombocythemiaP M Arlen, G A Goldkland
The Journal of Urology|May 29, 2017
Editorial CommentCharlotte Q Wu, Angela M Arlen
The Journal of Urology|May 21, 2020
Editorial CommentJamil S Syed, Angela M Arlen
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2005
Therapeutic vaccines for prostate cancer: a review of clinical dataPhilip M Arlen, James L Gulley
Future Oncology (London, England)|March 25, 2006
Docetaxel-based regimens, the standard of care for metastatic androgen-insensitive prostate cancerPhilip M Arlen, James L Gulley
Seminars in Pediatric Surgery|August 20, 2021
Armamentarium to treat primary vesicoureteral reflux in childrenAngela M Arlen, Andrew J Kirsch
Current Urology Reports|July 23, 2015
Controversies in the Management of Vesicoureteral RefluxAngela M Arlen, Christopher S Cooper
Expert Review of Medical Devices|December 25, 2015
Recent Developments in the Use of Robotic Technology in Pediatric UrologyAngela M Arlen, Andrew J Kirsch
Pageof 22

Showing results (21-30 of 215) with videos related to

Sort By:
Pageof 22
Idrugs : the Investigational Drugs Journal|December 24, 2005
Abiraterone. Cougar BiotechnologyRavi A Madan, Philip M Arlen
Expert Opinion on Biological Therapy|November 23, 2019
Rationale, discovery and clinical development of NEO-201Philip M Arlen, Maria Pia Morelli
Southern Medical Journal|January 1, 1995
Multiple myeloma after treatment of essential thrombocythemiaP M Arlen, G A Goldkland
The Journal of Urology|May 29, 2017
Editorial CommentCharlotte Q Wu, Angela M Arlen
The Journal of Urology|May 21, 2020
Editorial CommentJamil S Syed, Angela M Arlen
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2005
Therapeutic vaccines for prostate cancer: a review of clinical dataPhilip M Arlen, James L Gulley
Future Oncology (London, England)|March 25, 2006
Docetaxel-based regimens, the standard of care for metastatic androgen-insensitive prostate cancerPhilip M Arlen, James L Gulley
Seminars in Pediatric Surgery|August 20, 2021
Armamentarium to treat primary vesicoureteral reflux in childrenAngela M Arlen, Andrew J Kirsch
Current Urology Reports|July 23, 2015
Controversies in the Management of Vesicoureteral RefluxAngela M Arlen, Christopher S Cooper
Expert Review of Medical Devices|December 25, 2015
Recent Developments in the Use of Robotic Technology in Pediatric UrologyAngela M Arlen, Andrew J Kirsch
Pageof 22